A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Status unconfirmed

Conditions studied: HIV Disease, Herpes Simplex 1, Herpes Simplex 2

In brief

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

Key facts

Study ID

NCT05823779

Run by

Global Research Institute

People needed

50

Starts

2022-04-01

Expected to finish

2025-04-01

Last updated by the study team

2023-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject must be 18 years or older at the time of screening
• Males, Females, Transgender Male and Transgender Females
• HIV positive
• Positive antibody to HSV- 1/and or HSV-2
• If Female of child baring potential, documented negative pregnancy test at the time of screening.

You may not qualify if…

• Active opportunistic infection
• Current chemotherapy
• Unable to give informed consent

Where it is running

• Global Research Institute — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.